Cargando…
Initial Angiotensin Receptor Blocker Response in Young Marfan Patients Decreases After 3 Years of Treatment
Marfan syndrome is caused by mutations of the fibrillin-1 gene, which weakens the connective tissue integrity. Since 2003, bioavailability regulations of TGF-ß through fibrillin alterations have been presumed of being the culprit mechanisms for aortic aneurysm development. We present the analysis of...
Autores principales: | Pees, Christiane, Heno, Julian, Michel-Behnke, Ina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933348/ https://www.ncbi.nlm.nih.gov/pubmed/34757469 http://dx.doi.org/10.1007/s00246-021-02761-4 |
Ejemplares similares
-
Aortic elasticity deterioration proves intrinsic abnormality of the ascending aorta in pediatric Turner syndrome unrelated to the aortic valve morphology
por: Pees, Christiane, et al.
Publicado: (2018) -
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
por: Pitcher, Alex, et al.
Publicado: (2022) -
Blood pressure‐independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan
por: Tehrani, Arash Y., et al.
Publicado: (2021) -
Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center
por: Albinni, Sulaima, et al.
Publicado: (2023) -
β-blockers and Angiotensin Converting Enzyme Inhibitors: Comparison of Effects on Aortic Growth in Pediatric Patients with Marfan Syndrome
por: Phomakay, Venusa, et al.
Publicado: (2014)